Is this U.S.-China selloff a buy? A top Wall Street voice weighs in
PETACH TIKVA, Israel - Nanox Imaging Ltd (NASDAQ:NNOX), whose stock has shown impressive momentum with strong returns over the past week and month according to InvestingPro data, announced Thursday a collaboration with Monarch Medical Management and Billing LLC to deploy its imaging technology across multiple healthcare segments including workers’ compensation facilities, nursing homes, and outpatient clinics.
The partnership will establish an imaging network beginning with over a dozen initial sites for a proof-of-concept phase before planned nationwide expansion. Patients within Monarch’s network will gain access to Nanox’s imaging solutions, including the Nanox.ARC 3D digital tomosynthesis system, AI-powered software for analyzing CT scans, and teleradiology services. The company’s strong financial position, with liquid assets exceeding short-term obligations and more cash than debt on its balance sheet, supports its expansion capabilities.
"This collaboration addresses critical imaging access challenges across multiple healthcare segments by providing faster access to high-quality imaging services," said Erez Meltzer, Chief Executive Officer and Acting Chairman of Nanox, according to the company’s press release.
Monarch CEO Nydia Soriano stated that the integration of Nanox’s technology would enhance patient outcomes across diverse populations served by the healthcare management organization, which has operated for more than 30 years.
The collaboration aims to improve imaging accessibility for workers’ compensation claimants, nursing home residents, and outpatient clinic patients, potentially accelerating diagnosis and treatment decisions.
Nanox, which trades on the Nasdaq, focuses on preventive healthcare through affordable medical imaging technologies based on digital X-ray sources and advanced AI. The company’s ecosystem includes its tomosynthesis system, AI-based algorithms for CT image analysis, cloud-based software platform, and teleradiology services. Trading at low EBITDA and earnings multiples, the company presents an interesting value proposition according to InvestingPro, which offers 16 additional key insights about Nanox’s financial health and market position.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.